77 related articles for article (PubMed ID: 2816882)
21. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) does not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer.
Casini A; Pizzigallo AM; Mari F; Bertol E; Surrenti C
Am J Gastroenterol; 1994 May; 89(5):745-9. PubMed ID: 8172150
[TBL] [Abstract][Full Text] [Related]
22. Antacids and anticholinergics in the treatment of duodenal ulcer.
Walan A
Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
[TBL] [Abstract][Full Text] [Related]
23. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
24. [A cimetidine-pirenzepine combination in the treatment of patients with duodenal ulcer resistant to therapy with cimetidine or ranitidine. Our experience in 22 cases].
Capretti PG; Montalto C; Turi V; Gianni E; Marcolli G
Minerva Dietol Gastroenterol; 1988; 34(1):31-7. PubMed ID: 3386862
[No Abstract] [Full Text] [Related]
25. [Treatment of duodenal ulcer with famotidine].
Schütze K; Hentschel E; Reichel W; Kerstan E
Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224
[TBL] [Abstract][Full Text] [Related]
26. Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists.
Pöch G; Londong W
Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):483-8. PubMed ID: 8262686
[TBL] [Abstract][Full Text] [Related]
27. Effect of single nocturnal dose of pirenzepine versus ranitidine in duodenal ulcer.
Contractor QQ; Benson L; Contractor TQ; Schulz T
Indian J Gastroenterol; 1988 Jul; 7(3):165-6. PubMed ID: 3397140
[No Abstract] [Full Text] [Related]
28. [I.v. famotidine versus i.v. ranitidine: intragastric pH behavior in surgical intensive care patients].
Friedl W; Krier C; Dammann HG; Müller P; Simon B
Z Gastroenterol; 1985 Nov; 23(11):603-7. PubMed ID: 2868579
[TBL] [Abstract][Full Text] [Related]
29. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
[TBL] [Abstract][Full Text] [Related]
30. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
31. Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcer.
Wilder-Smith CH; Halter F; Merki HS
Dig Dis Sci; 1991 Dec; 36(12):1685-90. PubMed ID: 1748035
[TBL] [Abstract][Full Text] [Related]
32. High doses of ranitidine in maintenance therapy of duodenal ulcer patients.
Lee FI
Scand J Gastroenterol Suppl; 1990; 178():67-71. PubMed ID: 2277970
[TBL] [Abstract][Full Text] [Related]
33. [Duodenal ulcer, study of gastric secretion and rational treatment with famotidine in different doses].
Santoro E; Morucci P; Idotta G; Scutari F
Ann Gastroenterol Hepatol (Paris); 1989 Oct; 25(5):211-4. PubMed ID: 2817767
[TBL] [Abstract][Full Text] [Related]
34. Famotidine in the short and long-term treatment of duodenal ulcer.
Zaterka S; de Paula Castro L; Villalobos JJ; Massuda HK; Eisig JN; Dias Avelar C; Coelho LG; Bettarello A
Acta Gastroenterol Latinoam; 1988; 18(2):115-21. PubMed ID: 3075106
[TBL] [Abstract][Full Text] [Related]
35. [24-hour intragastric acid profile in a ZES patient with H2 blockers].
Dammann HG; Müller P; Simon B; Kommerell B
Z Gastroenterol; 1984 Jun; 22(6):318-20. PubMed ID: 6147052
[No Abstract] [Full Text] [Related]
36. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
[TBL] [Abstract][Full Text] [Related]
37. Duodenal and gastric ulcer healing rates: a review.
Legerton CW
Am J Med; 1984 Nov; 77(5B):2-7. PubMed ID: 6095656
[TBL] [Abstract][Full Text] [Related]
38. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
39. [Josamycin combination with ranitidine in therapy of gastroduodenal ulcer: clinical efficiency].
Maev IV; Vertkin AL; Vovk EI; Masharova AA; Bezborodnyĭ SD; Lebedeva EG
Klin Med (Mosk); 2000; 78(3):46-50. PubMed ID: 10790966
[TBL] [Abstract][Full Text] [Related]
40. Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide.
Reynolds JC
Clin Ther; 1988; 10(4):436-49. PubMed ID: 3079011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
